Get notified when TLRY files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- We Depend On Recurring Customers For a Substantial Portion of Our Revenue (new) — The company discloses significant customer concentration, though no specific customers are named.
- New U.s. Federal Regulation Which Was Enacted and Banned the Production or Sale of Hemp-derived Cannabis, Including Delta-9 (new) — A specific regulatory ban on hemp-derived cannabis products is scheduled to take effect in November 2026, directly impacting Tilray's product lines.
Tilray launches up to $180M at-the-market stock offering at $6.91/share, proceeds for acquisitions
Filed April 15, 2026 · ~1 min read
Key Changes
-
high
Tilray may sell up to $180M of common stock from time to time through sales agents at market prices; no minimum amount is required.
The Offering verify on EDGAR → -
high
Net proceeds are earmarked for strategic and accretive acquisitions or investments, not working capital; management has broad discretion.
Use of Proceeds verify on EDGAR → -
medium
At the assumed offering price of $6.91, the company could issue up to 26,049,204 shares, resulting in up to 144,485,331 shares outstanding.
The Offering verify on EDGAR →
4 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SNX 10-Q) is open in full — no account needed.
Partner
Trade TLRY commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify